OBJECTIVE: To assess individual compliance with annual ivermectin treatment in onchocerciasis-endemic villages. METHODS: Multi-site study in eight APOC-sponsored projects in Cameroon, Nigeria and Uganda to identify the socio-demographic correlates of compliance with ivermectin treatment. A structured questionnaire was administered on 2305 persons aged 10 years and above. Two categories of respondents were purposively selected to obtain both high and low compliers: people who took ivermectin 6-8 times and 0-2 times previously. Simple descriptive statistics were employed in characterizing the respondents into high and low compliers, while some socio-demographic and key perceptual factors were employed in regression models constructed to explain levels of compliance among the respondents. RESULTS: Some demographic and perceptual factors associated with compliance were identified. Compliance was more common among men (54.4%) (P < 0.001). Adults (54.6%) had greater rates of high compliance (P < 0.001. The mean age of high compliers (41.5 years) was significantly older (35.8 years) (t = 8.46, P < 0.001). Perception of onchocerciasis and effectiveness of ivermectin influenced compliance. 81.4% of respondents saw benefits in annual ivermectin treatment, high compliance among those who saw benefits was 59.3% compared to 13.3% of those who did not (P < 0.001). CONCLUSION: Efforts to increase compliance with ivermectin treatment should focus on providing health education to youth and women. Health education should also highlight the benefits of taking ivermectin.
OBJECTIVE: To assess individual compliance with annual ivermectin treatment in onchocerciasis-endemic villages. METHODS: Multi-site study in eight APOC-sponsored projects in Cameroon, Nigeria and Uganda to identify the socio-demographic correlates of compliance with ivermectin treatment. A structured questionnaire was administered on 2305 persons aged 10 years and above. Two categories of respondents were purposively selected to obtain both high and low compliers: people who took ivermectin 6-8 times and 0-2 times previously. Simple descriptive statistics were employed in characterizing the respondents into high and low compliers, while some socio-demographic and key perceptual factors were employed in regression models constructed to explain levels of compliance among the respondents. RESULTS: Some demographic and perceptual factors associated with compliance were identified. Compliance was more common among men (54.4%) (P < 0.001). Adults (54.6%) had greater rates of high compliance (P < 0.001. The mean age of high compliers (41.5 years) was significantly older (35.8 years) (t = 8.46, P < 0.001). Perception of onchocerciasis and effectiveness of ivermectin influenced compliance. 81.4% of respondents saw benefits in annual ivermectin treatment, high compliance among those who saw benefits was 59.3% compared to 13.3% of those who did not (P < 0.001). CONCLUSION: Efforts to increase compliance with ivermectin treatment should focus on providing health education to youth and women. Health education should also highlight the benefits of taking ivermectin.
Authors: Germanus S Bah; Emma L Ward; Abhishek Srivastava; Alexander J Trees; Vincent N Tanya; Benjamin L Makepeace Journal: Antimicrob Agents Chemother Date: 2013-11-18 Impact factor: 5.191
Authors: David J Blok; Joseph Kamgno; Sebastien D Pion; Hugues C Nana-Djeunga; Yannick Niamsi-Emalio; Cedric B Chesnais; Charles D Mackenzie; Amy D Klion; Daniel A Fletcher; Thomas B Nutman; Sake J de Vlas; Michel Boussinesq; Wilma A Stolk Journal: Clin Infect Dis Date: 2021-06-15 Impact factor: 9.079
Authors: Goylette F Chami; Andreas A Kontoleon; Erwin Bulte; Alan Fenwick; Narcis B Kabatereine; Edridah M Tukahebwa; David W Dunne Journal: Clin Infect Dis Date: 2015-09-25 Impact factor: 9.079
Authors: Laura Senyonjo; Joseph Oye; Didier Bakajika; Benjamin Biholong; Afework Tekle; Daniel Boakye; Elena Schmidt; Elizabeth Elhassan Journal: PLoS Negl Trop Dis Date: 2016-08-16
Authors: Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez Journal: PLoS Negl Trop Dis Date: 2013-04-25